Natco Pharma Clarifies Recent Volume Surge to BSE, Cites Market Conditions
Natco Pharma Limited clarified to BSE that recent trading volume increases are market-driven, confirming full compliance with SEBI disclosure regulations. The company stated it has made all necessary disclosures under Regulation 30 and has not withheld material information affecting share volume behavior. Company Secretary Ch. Venkat Ramesh signed the February 25, 2026 response addressing BSE's volume movement inquiry.
*this image is generated using AI for illustrative purposes only.
Natco Pharma Limited has issued a clarification to BSE Limited regarding the recent increase in trading volumes of its shares, attributing the surge to market-driven factors. The pharmaceutical company's response, dated February 25, 2026, addresses BSE's inquiry under reference L/SURV/ONL/PV/SG/2025-2026/935.
Regulatory Compliance and Disclosure
The company emphasized its adherence to regulatory requirements in its communication to the stock exchange. Key aspects of the clarification include:
| Parameter: | Details |
|---|---|
| Regulation Compliance: | SEBI (LODR) Regulations, 2015 |
| Disclosure Status: | All necessary disclosures made |
| Price Sensitive Information: | Fully disclosed |
| Material Information: | No withholding reported |
Volume Movement Explanation
Natco Pharma stated that the increased trading volume in its shares is purely market-driven and results from prevailing market conditions. The company clarified that it has not withheld any material or price-sensitive information that could influence the volume behavior of its shares.
Corporate Communication Details
The clarification letter was signed by Ch. Venkat Ramesh, Company Secretary and Compliance Officer, on February 25, 2026. The response confirms that all disclosures pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, have been made, covering information that bears on the company's operations and performance.
Regulatory Framework
The communication falls under the standard regulatory framework where stock exchanges monitor unusual price or volume movements and seek clarifications from listed companies. Natco Pharma's response demonstrates its commitment to transparency and regulatory compliance in addressing market inquiries.
Historical Stock Returns for Natco Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.51% | +10.55% | +17.56% | +10.83% | +18.82% | +21.38% |
20
